Peter Krüger

5.3k total citations
71 papers, 1.9k citations indexed

About

Peter Krüger is a scholar working on Epidemiology, Surgery and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Peter Krüger has authored 71 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 17 papers in Surgery and 13 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Peter Krüger's work include Sepsis Diagnosis and Treatment (23 papers), Cardiac, Anesthesia and Surgical Outcomes (10 papers) and Lipoproteins and Cardiovascular Health (8 papers). Peter Krüger is often cited by papers focused on Sepsis Diagnosis and Treatment (23 papers), Cardiac, Anesthesia and Surgical Outcomes (10 papers) and Lipoproteins and Cardiovascular Health (8 papers). Peter Krüger collaborates with scholars based in Australia, United Kingdom and Canada. Peter Krüger's co-authors include Balasubramanian Venkatesh, Mark Jones, Jeffrey Lipman, Jason A. Roberts, David L. Paterson, Michael S. Roberts, Rinaldo Bellomo, David J. Cook, Graeme R. Nimmo and Anand Krishnan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Peter Krüger

65 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Krüger Australia 24 748 445 405 297 288 71 1.9k
Mojtaba Mojtahedzadeh Iran 23 485 0.6× 259 0.6× 322 0.8× 327 1.1× 145 0.5× 166 1.8k
Erin F. Barreto United States 25 588 0.8× 309 0.7× 443 1.1× 287 1.0× 723 2.5× 155 2.2k
Hendrik Bracht Germany 21 697 0.9× 371 0.8× 677 1.7× 278 0.9× 203 0.7× 75 1.9k
Atabak Najafi Iran 22 381 0.5× 461 1.0× 187 0.5× 248 0.8× 188 0.7× 156 1.8k
Angelo Raffaele De Gaudio Italy 29 608 0.8× 672 1.5× 244 0.6× 529 1.8× 457 1.6× 106 2.6k
Thierry Dugernier Belgium 28 971 1.3× 723 1.6× 670 1.7× 282 0.9× 311 1.1× 53 2.7k
R. Gauzit France 26 854 1.1× 513 1.2× 385 1.0× 550 1.9× 111 0.4× 88 2.6k
Tyree H. Kiser United States 29 472 0.6× 520 1.2× 282 0.7× 347 1.2× 128 0.4× 135 2.4k
Claire V. Murphy United States 22 562 0.8× 451 1.0× 136 0.3× 465 1.6× 150 0.5× 85 1.7k
Thorsten Brenner Germany 29 1.2k 1.5× 500 1.1× 315 0.8× 579 1.9× 141 0.5× 184 3.1k

Countries citing papers authored by Peter Krüger

Since Specialization
Citations

This map shows the geographic impact of Peter Krüger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Krüger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Krüger more than expected).

Fields of papers citing papers by Peter Krüger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Krüger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Krüger. The network helps show where Peter Krüger may publish in the future.

Co-authorship network of co-authors of Peter Krüger

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Krüger. A scholar is included among the top collaborators of Peter Krüger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Krüger. Peter Krüger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Patrick N. A., Michelle J. Bauer, Stephan Beisken, et al.. (2024). Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis. Microbiology Spectrum. 12(2). e0306523–e0306523. 15 indexed citations
2.
3.
Dimeski, Goce & Peter Krüger. (2021). Interference by piperacillin/tazobactam in the measurement of creatinine with the Jaffe method and of total protein with the biuret method. Critical Care and Resuscitation. 23(2). 141–143. 2 indexed citations
4.
Marshall, Andrea P., Diane Chamberlain, Lee‐anne S. Chapple, et al.. (2020). A critical care pandemic staffing framework in Australia. Australian Critical Care. 34(2). 123–131. 26 indexed citations
5.
Nagendran, Myura, Daniel F. McAuley, Peter Krüger, et al.. (2016). Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials. Intensive Care Medicine. 43(5). 663–671. 30 indexed citations
6.
Liu, Xin, Peter Krüger, Howard I. Maïbach, Paul B. Colditz, & Michael S. Roberts. (2014). Using skin for drug delivery and diagnosis in the critically ill. Advanced Drug Delivery Reviews. 77. 40–49. 29 indexed citations
7.
Flannery, Alexander H. & Peter Krüger. (2014). POINT: Should Patients Receiving Statins Prior to ICU Admission Be Continued on Statin Therapy? Yes. CHEST Journal. 146(6). 1431–1433. 1 indexed citations
8.
Young, Paul J., et al.. (2013). A case series of critically ill patients with anti-N-methyl-Daspartate receptor encephalitis. Critical Care and Resuscitation. 15(1). 8–14. 8 indexed citations
9.
Krüger, Peter, Michael Bailey, Rinaldo Bellomo, et al.. (2013). A Multicenter Randomized Trial of Atorvastatin Therapy in Intensive Care Patients with Severe Sepsis. American Journal of Respiratory and Critical Care Medicine. 187(7). 743–750. 148 indexed citations
10.
Krüger, Peter & Balasubramanian Venkatesh. (2013). Are There Any Benefits from Statin Treatment for the Septic Patient?. Current Atherosclerosis Reports. 16(1). 378–378. 7 indexed citations
11.
Young, Paul J., Carol Hodgson, Joel M. Dulhunty, et al.. (2012). End points for Phase II trials in intensive care: recommendations from the Australian and New Zealand Clinical Trials Group consensus panel meeting. Critical Care and Resuscitation. 14(3). 211–215. 44 indexed citations
12.
Liu, Xin, Peter Krüger, Michael Weiß, & Michael S. Roberts. (2011). The pharmacokinetics and pharmacodynamics of cisatracurium in critically ill patients with severe sepsis. British Journal of Clinical Pharmacology. 73(5). 741–749. 7 indexed citations
13.
Iyer, Vikram, et al.. (2011). Epidemiology and significance of coagulase-negative staphylococci isolated in blood cultures from critically ill adult patients. Critical Care and Resuscitation. 13(2). 103–107. 8 indexed citations
14.
Liu, Xin, Peter Krüger, & Michael S. Roberts. (2011). How to Measure Pharmacokinetics in Critically Ill Patients?. Current Pharmaceutical Biotechnology. 12(12). 2037–2043. 7 indexed citations
15.
Krüger, Peter, Meg Harward, Mark Jones, et al.. (2010). Continuation of Statin Therapy in Patients with Presumed Infection: A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 183(6). 774–781. 82 indexed citations
16.
Venkatesh, Balasubramanian, et al.. (2008). Basic science research in Australian intensive care practice. Critical Care and Resuscitation. 10(1). 47–52. 4 indexed citations
17.
Munckhof, Wendy, Anand Krishnan, Peter Krüger, & David Looke. (2008). Cavernous sinus thrombosis and meningitis from community‐acquired methicillin‐resistant Staphylococcus aureus infection. Internal Medicine Journal. 38(4). 283–287. 24 indexed citations
18.
Roberts, Jason A., Peter Krüger, David L. Paterson, & Jeffrey Lipman. (2008). Antibiotic resistance—What’s dosing got to do with it?. Critical Care Medicine. 36(8). 2433–2440. 259 indexed citations
19.
Krüger, Peter. (2006). Statins: the next anti-endotoxin. Critical Care and Resuscitation. 8(3). 223–226. 16 indexed citations
20.
Krüger, Peter, et al.. (2006). INDOCYANINE GREEN ELIMINATION: A COMPARISON OF THE LiMON AND SERIAL BLOOD SAMPLING METHODS. ANZ Journal of Surgery. 76(1-2). 75–77. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mojtaba Mojtahedzadeh Breakdown of academic impact, for papers by Erin F. Barreto Breakdown of academic impact, for papers by Hendrik Bracht Breakdown of academic impact, for papers by Atabak Najafi Breakdown of academic impact, for papers by Angelo Raffaele De Gaudio Breakdown of academic impact, for papers by Thierry Dugernier Breakdown of academic impact, for papers by R. Gauzit Breakdown of academic impact, for papers by Tyree H. Kiser Breakdown of academic impact, for papers by Claire V. Murphy Breakdown of academic impact, for papers by Thorsten Brenner
Rankless by CCL
2026